Source:http://linkedlifedata.com/resource/pubmed/id/18079150
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-2-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1460-2385
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
777
|
pubmed:meshHeading |
pubmed-meshheading:18079150-Aged,
pubmed-meshheading:18079150-Bone Neoplasms,
pubmed-meshheading:18079150-Glomerulonephritis, Membranoproliferative,
pubmed-meshheading:18079150-Humans,
pubmed-meshheading:18079150-Immunosuppressive Agents,
pubmed-meshheading:18079150-Male,
pubmed-meshheading:18079150-Prostatic Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
Membrano-proliferative glomerulonephritis associated with metastatic prostate carcinoma--should immunosuppressive therapy be considered?
|
pubmed:publicationType |
Letter,
Case Reports
|